Literature DB >> 19726933

Telemetry monitoring guidelines for efficient and safe delivery of cardiac rhythm monitoring to noncritical hospital inpatients.

Sandeep K Dhillon1, Maurice Rachko, Sam Hanon, Paul Schweitzer, Steven R Bergmann.   

Abstract

Telemetry monitoring is a limited resource in most hospitals. Few clinical studies have established firm criteria for inpatient telemetry. At our urban institution, we have developed and incorporated guidelines to identify patients who benefit from cardiac rhythm monitoring. These guidelines serve to minimize inappropriate use of telemetry beds, thereby preventing emergency department overcrowding and ambulance diversion. This improvement in efficiency is achieved without compromising health care.

Entities:  

Mesh:

Year:  2009        PMID: 19726933     DOI: 10.1097/HPC.0b013e3181b6ef41

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN: 1535-2811


  3 in total

1.  Unnecessary arrhythmia monitoring and underutilization of ischemia and QT interval monitoring in current clinical practice: baseline results of the Practical Use of the Latest Standards for Electrocardiography trial.

Authors:  Marjorie Funk; Catherine G Winkler; Jeanine L May; Kimberly Stephens; Kristopher P Fennie; Leonie L Rose; Yasemin E Turkman; Barbara J Drew
Journal:  J Electrocardiol       Date:  2010-09-15       Impact factor: 1.438

2.  Effectiveness of Telemetry Guidelines in Predicting Clinically Significant Arrhythmias in Hospitalized Patients.

Authors:  Sandeep K Dhillon; Baruch Goldstein; Dayana Eslava-Manchego; Jagdeep Singh; Sam Hanon; Paul Schweitzer; Steven R Bergmann
Journal:  Cardiol Res       Date:  2012-01-20

3.  Monitoring the Use of Telemonitor: A Resident-run Quality Improvement Initiative Decreases Inappropriate Use of Telemonitor in a Community Hospital.

Authors:  Tinashe Maduke; Binish Qureshi; Yohannes Goite; Khushboo Gandhi; Fadel Bofarrag; Lin Liu; Miguel Suazo; Sehrish Khan; Samjhana Basnyat; Suresh Dhital; Hameem Kawsar
Journal:  Cureus       Date:  2019-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.